Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.
Bousquet G, Confavreux C, Magné N, de Lara CT, Poortmans P, Senkus E, de Lafontan B, Bolla M, Largillier R, Lagneau E, Kadish S, Lemanski C, Ozsahin M, Belkacémi Y. Bousquet G, et al. Among authors: de lara ct, de lafontan b. Radiother Oncol. 2007 Dec;85(3):355-61. doi: 10.1016/j.radonc.2007.10.015. Epub 2007 Nov 26. Radiother Oncol. 2007. PMID: 18023492
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y. Cutuli B, et al. Among authors: de lara ct, de lafontan b. Crit Rev Oncol Hematol. 2010 Mar;73(3):246-54. doi: 10.1016/j.critrevonc.2009.04.002. Epub 2009 May 12. Crit Rev Oncol Hematol. 2010. PMID: 19442535
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
Cutuli B, Lemanski C, De Lafontan B, Chauvet MP, De Lara CT, Mege A, Fric D, Richard-Molard M, Mazouni C, Cuvier C, Carre A, Kirova Y. Cutuli B, et al. Among authors: de lara ct. Clin Breast Cancer. 2020 Apr;20(2):e164-e172. doi: 10.1016/j.clbc.2019.08.002. Epub 2019 Aug 22. Clin Breast Cancer. 2020. PMID: 31780381 Free article.
[Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases].
Cutuli B, Lemanski C, Fourquet A, de Lafontan B, Giard S, Lancrenon S, Meunier A, Pioud-Martigny R, Campana F, Marsiglia H, Mery E, Penault-Llorca F, Fondrinier E, de Lara CT. Cutuli B, et al. Among authors: de lara ct, de lafontan b. Bull Cancer. 2010 Mar;97(3):301-10. doi: 10.1684/bdc.2010.1048. Bull Cancer. 2010. PMID: 20159677 French.
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.
Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE, Gimbergues P, Chauvet MP, Azuar AS, Rouzier R, de Lara CT, Muracciole X, Agostini A, Gonçalves A, Lambaudie E. Houvenaeghel G, et al. Among authors: de lara ct. Breast Cancer Res Treat. 2019 Jan;173(1):111-122. doi: 10.1007/s10549-018-4944-2. Epub 2018 Sep 20. Breast Cancer Res Treat. 2019. PMID: 30238274
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆.
Houvenaeghel G, de Nonneville A, Cohen M, Chopin N, Coutant C, Reyal F, Mazouni C, Gimbergues P, Azuar AS, Chauvet MP, Classe JM, Daraï E, Martinez A, Rouzier R, de Lara CT, Lambaudie E, Barrou J, Goncalves A. Houvenaeghel G, et al. Among authors: de lara ct. ESMO Open. 2021 Jun;6(3):100151. doi: 10.1016/j.esmoop.2021.100151. Epub 2021 May 10. ESMO Open. 2021. PMID: 33984674 Free PMC article.
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.
de Nonneville A, Jauffret C, Gonçalves A, Classe JM, Cohen M, Reyal F, Mazouni C, Chauvet MP, Chopin N, Colombo PE, Jouve E, Darai E, Rouzier R, Coutant C, Gimbergues P, Azuar AS, de Lara CT, Lambaudie E, Houvenaeghel G. de Nonneville A, et al. Among authors: de lara ct. Breast Cancer Res Treat. 2019 Jun;175(2):379-387. doi: 10.1007/s10549-019-05160-9. Epub 2019 Feb 13. Breast Cancer Res Treat. 2019. PMID: 30759288 Clinical Trial.
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N. Donker M, et al. Among authors: de lara ct. J Clin Oncol. 2013 Nov 10;31(32):4054-9. doi: 10.1200/JCO.2013.49.5077. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043739 Clinical Trial.
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival.
Lambaudie E, Houvenaeghel G, Ziouèche A, Knight S, Dravet F, Garbay JR, Giard S, Charitansky H, Cohen M, Faure C, Hudry D, Azuar P, Villet R, Gimbergues P, de Lara CT, Tallet A, Bannier M, Minsat M, Resbeut M. Lambaudie E, et al. Among authors: de lara ct. BMC Surg. 2016 Nov 15;16(1):74. doi: 10.1186/s12893-016-0191-9. BMC Surg. 2016. PMID: 27846840 Free PMC article.
30 results